Skip to main content
U.S. Department of Health & Human Services
  • CSR Extranet
  • Staff Directory
  • Contact CSR
National Institutes of Health: Center for Scientific Review
  • For Applicants
  • For Reviewers
  • Study Sections
  • Review Meetings
  • Evaluation Initiatives
  • About CSR
  • CSR Employee Intranet
  • Staff Directory
  • Contact CSR
  • Application Process
  • Planning & Writing
  • Due Dates
  • Submission & Assignment
  • Initial Review, Results, & Appeals
  • Frequently Asked Questions (FAQs)

For Applicants

CSR’s primary role is to handle the receipt and review of all grant applications that NIH receives. NIH separates the review process from funding decisions.

  • Reviewer Recruitment
  • Reviewer Resources
  • Travel & Reimbursement
  • Frequently Asked Questions (FAQs)

For Reviewers

Reviewers are critical to our mission to see that NIH grant applications receive, fair, independent, expert, and timely scientific reviews. We appreciate the generosity with which reviewers give their time.

Study Sections

Applications are reviewed in study sections (Scientific Review Groups, SRGs). Review Branches (RBs) are clusters of study sections based on scientific discipline.

  • Review Branches
  • Standing Study Sections
  • Small Business & Technology Transfer
  • Fellowship
  • Special Emphasis
  • HIV/AIDS Research

Review Meetings

Applications are reviewed in study sections (Scientific Review Groups, SRGs). Review Branches (RBs) are clusters of study sections based on scientific discipline.

  • Search Panels
  • Search Meeting Dates
  • Meeting Overview
  • CSR Peer Review Webinars & Videos

Evaluation Initiatives

Access data visualizations, reports, and analytical tools to track progress.

  • CSR Data & Evaluations
  • Strengthening Peer Review
  • ENQUIRE Reviews

About CSR

  • CSR Mission
  • CSR Director
  • CSR Organization
  • Public Meetings - Materials
  • News & Updates
  • Strategic Plan

CSR SS Search

Study Section Description Scientific Review Officer
ZRG1 BTC-Y (81) Topics in Basic and Translational Cancer Research Dr. David Ransom
ZRG1 CCHI-K (57) PAR Panel: Mental Health and Alzheimer's Disease & Related Dementias (ADRD) Interventions and Outcomes Dr. Karin Garg
ZRG1 CCHI-Q (57) PAR Panel: Topics in HIV/AIDS: Health Interventions, Clinical Care, and Treatment Dr. Xinli Nan
ZRG1 CDB-C (90) The Biology of Visual Science
ZRG1 CDB-V (90) Topics in Cellular Mechanisms of Aging and Development Dr. Mirela Milescu
ZRG1 CDB-Z (55) PAR-23-145: Maximizing Investigators Research Award for Early Stage Investigators Dr. Konrad Krzewski
ZRG1 CDPT-A (08) Biomarkers for Cancer Diagnosis and Therapy Dr. Asifa Haider
ZRG1 CDPT-F (56) PAR-24-274: NCI Research Specialist Award (R50) Dr. Shree Ram Singh
ZRG1 CDPT-H (55) PAR Panel: Cancer Etiology, Diagnosis, Prevention and Treatment Dr. Hasan Siddiqui
ZRG1 CFS-W (80) Myalgic Encephalomyelitis-Chronic Fatigue Syndrome Dr. Myongsoo Oh
ZRG1 CN-F (92) Topics in Clinical Neuroimmunology and Brain Tumors Dr. Dario Dieguez
ZRG1 CN-M (82) Neurodevelopmental and Neuropsychiatric Disorders Dr. Patricia Kraemer
ZRG1 CN-Q (85) Immune Signaling in Neurological Disorders and Infectious Diseases Dr. Iqbal Sayeed
ZRG1 CN-W (54) PAR's Panel: Rare Diseases Clinical Research Consortia Dr. Anita Tandle
ZRG1 DCAI-B (80) Diagnostics, Surveillance, Microbiology, and Immunology of Infectious Diseases Dr. Shinako Takada
ZRG1 DCAI-D (02) Member Conflict: Topics in Infectious Diseases Dr. Dayadevi Jirage
ZRG1 DCAI-D (50) Par Panel: Enhancing Mechanistic Research on Precision Probiotic Therapies. Dr. Dayadevi Jirage
ZRG1 DCAI-S (40) RFA-25-035: Influenza Transmission Research Consortium Dr. Liangbiao Zheng
ZRG1 DCAI-V (89) Early Development of Vaccines Against Infectious Diseases Dr. Vanitha Raman
ZRG1 DCAI-Z (51) Rational Design of Vaccines Against Hepatitis C Virus (U19 Clinical Trial Not Allowed) Dr. Samita Andreansky
ZRG1 EMS-G (55) High Impact, Interdisciplinary Science in NIDDK Research Areas AND Advancing Research on the Application of Digital Health Technology to the Management of Type 2 DM Study Section Meeting Dr. Dawanna James-Holly
ZRG1 EMS-H (50) PAR-25-438: Rare Diseases Clinical Research Consortia for the Rare Diseases Clinical Research Network Dr. Latha Malaiyandi
ZRG1 EMS-M (55) RFA-HD-26-001: Development of Novel or Improved Infertility Technologies Dr. Thomas O'Farrell
ZRG1 EMS-Q (02) Member Conflict: Topics in Endocrinology, Metabolism and Reproductive Systems Dr. Joshua Park
ZRG1 EMS-Q (08) Endocrinology, Metabolism, and Nutrition Dr. Joshua Park

Pagination

  • Previous page ‹‹
  • Next page ››

User account menu

 

  • Contact Us
  • X
  • YouTube
  • LinkedIn
  • More Social Media from NIH
National Institutes of Health: Center for Scientific Review National Institutes of Health: Center for Scientific Review
National Institutes of Health, Center for Scientific Review
6701 Rockledge Drive MSC 7768, Bethesda MD 20817
(301) 435-1111

Site Map

CSR Home

For Applicants

  • Application Process
  • Planning & Writing
  • Due Dates
  • Submission & Assignment
  • Initial Review, Results, & Appeals
  • Frequently Asked Questions (FAQs)

For Reviewers

  • Become a Reviewer
  • Reviewer Resources
  • Travel & Reimbursement
  • Frequently Asked Questions (FAQs)

Study Sections

  • Review Branches
  • Standing Study Sections
  • Small Business & Technology Transfer
  • Fellowship
  • Special Emphasis
  • HIV/AIDS Research

Review Meetings

  • Search Panels
  • Search Meeting Dates
  • Meeting Overview
  • CSR Peer Review Webinars & Videos

Evaluation Initiatives

  • CSR Data & Evaluations
  • Strengthening Peer Review
  • ENQUIRE Reviews

About CSR

  • CSR Mission
  • CSR Director
  • CSR Organization
  • Public Meetings - Materials
  • News & Updates
  • Strategic Plan

Employment


United States Department of Health & Human Services United States Department of Health & Human Services
National Institutes of Health National Institutes of Health
USA.gov USA.gov

  • FOIA
  • Disclaimer & Privacy Statements
  • Accessibility Statements
  • HHS Vulnerability Disclosure